Clinical trial · Interventional
Natural Orifice Transluminal Endoscopic Surgery for Colorectal Cancer
NCT02549456CI-TRIAL-00026614NOTESunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to assess different hybrid natural orifice transluminal endoscopic surgery techniques in management of colorectal cancer as regard: feasibility of the technique, short term oncologic outcome and functional outcome.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Laparoendoscopic resection | Procedure | — | UNRESOLVED |
| natural orifice specimen extraction | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Natural orifice specimen extraction
- description
- Conventional laparoscopic resection of colorectal cancer with natural orifice specimen extraction
- interventionNames
- Procedure: natural orifice specimen extraction
- type
- EXPERIMENTAL
- label
- Laparoendoscopic resection
- description
- Laparoscopic assisted transanal endoscopic resection of rectal cancer
- interventionNames
- Procedure: Laparoendoscopic resection
Primary outcomes (6)
- measure
- Feasibility
- timeFrame
- 24 hour
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. Medically fit patient. 2. Non metastatic pathologically proven sigmoid colon cancer. 3. Non metastatic pathologically proven rectal cancer. 4. Patient continent for stool. Exclusion Criteria: 1. Patients with American Society of Anesthesiologist (ASA) score 4 and 5. 2. Patients with cardiac or chest problems that cannot withstand insufflation. 3. Unresectable tumors (defined as those who cannot be resected without a high likelihood of leaving microscopic or gross residual disease at the local site because of tumor adherence or fixation). 4. Obstructed or perforated cancer. 5. Patients with metastatic colorectal cancer. 6. Incontinent patients.
References
Publications (0)
Data not yet available
No reference posted for this study.